Related Experiment Video

Updated: Jun 6, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

[Expression and clinical significance of Pokemon in non-small cell lung cancer]

Zhihong Zhao1, Shengfa Wang, Tiewa Zhang

  • 1Department of Chest Surgery,the First Affiliated Clinical Hospital,Harbin Medical University,Harbin,Heilongjiang 150001,P.R.China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|December 7, 2010
PubMed
Abstract

Insights

Pokemon gene is highly expressed in most non-small cell lung cancer (NSCLC) tissues, correlating with advanced TNM stages. High Pokemon expression indicates a poor prognosis for NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Proto-oncogene Pokemon regulates cell growth via the ARF-p53 pathway.
  • Pokemon's upstream position to tumor suppressors suggests its role in tumorigenesis.
  • Understanding Pokemon's role is crucial for non-small cell lung cancer (NSCLC) research.

Purpose:

  • To investigate the clinical significance of Pokemon gene expression in NSCLC.
  • To determine the correlation between Pokemon expression and NSCLC clinicopathological features and prognosis.

Summary:

  • Pokemon protein was detected in 71.7% of NSCLC tissues but not in adjacent healthy tissues.
  • Pokemon expression positively correlated with advanced TNM stages in NSCLC patients.
  • High Pokemon expression was linked to significantly lower survival rates and identified as an independent prognostic factor.

Impact:

  • Pokemon expression serves as a potential diagnostic marker for NSCLC.
  • Elevated Pokemon levels may predict a poorer prognosis in NSCLC patients.
  • This finding opens avenues for targeted therapies and improved patient stratification.

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...